6 June 2021 Blog Plans for a multilateral pharmaceutical merger task force The aim is to identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers, and address perceived harms around price increases and anti-competitive conduct. Share this article Bookmark this page 2 min read
24 May 2021 Blog EU Parliament calls for review of UK's data privacy regime The European Parliament has asked the EU Commission to take another look at the UK's data protection adequacy assessment. Share this article Bookmark this page 1 min read
18 May 2021 Blog Issues to consider when exploiting commercial opportunities in People’s Republic of China As the Chinese life sciences market continues to grow and develop, the Chinese government continues to de-regulate or streamline its regulatory pathways (such as its drug approval regimes). And as Chinese parties seek to exploit foreign technologies... Share this article Bookmark this page 4 min read
22 April 2021 Blog EU bid to control the future of AI This week saw the publication of long-expected draft EU legislation aimed at regulating artificial intelligence systems of all kinds. These broad proposals indicate a willingness to take an... Share this article Bookmark this page 1 min read
22 April 2021 Blog UK considers reform to GMO regulations As explained in DEFRA’s supporting documents, GMOs generally involve the introduction of genetic material into an organism. The classic example is lifting DNA from one species and inserting into a... Share this article Bookmark this page 3 min read
10 March 2021 Blog Next steps for life sciences regulation in the UK As the UK's Medicines and Medical Devices Act 2021 becomes law, we review what... Share this article Bookmark this page 1 min read
22 February 2021 Blog Good news for EEA/UK personal data flows The EU Commission has now published draft adequacy decisions for transfers of personal data to the United Kingdom, under both the GDPR and the Law Enforcement Directive. This is welcome news, as it will provide a greater degree of certainty... Share this article Bookmark this page 2 min read
6 January 2021 Blog The EU-UK Trade and Cooperation Agreement - life sciences December's announcement of a Trade and Cooperation Agreement to steer the next steps in the future relationship between the UK and the EU was a welcome development. Share this article Bookmark this page 1 min read
27 October 2020 Blog UK will access new regulatory partnerships from the start of 2021 Members of the European Union operate closely coordinated medicines approval systems, with innovative products coming within the remit of the EMEA for central approval. Share this article Bookmark this page 1 min read
6 October 2020 Blog CRISPR pioneers awarded Nobel Prize We are delighted to learn of the The Royal Swedish Academy of Sciences to give the 2020 Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna. Share this article Bookmark this page 1 min read
1 October 2020 Blog The UK life sciences market after December 2020 – clinical trials UK Government has issued new Brexit guidance for the life sciences sector. With the transition period coming to an end on 31 December, only three months remain before the Medicines and Healthcare products Regulatory Agency (MHRA) takes on... Share this article Bookmark this page 2 min read
10 September 2020 Blog The UK life sciences market after December 2020 - licensing of medicinal products In this article, we take a look at the guidance on licensing of medicines and related products, particularly marketing authorisations. This addresses the following topics... Share this article Bookmark this page 3 min read